Back to 
UBS Group AGCMCMTA
UBS Group AGCMCMTA2 quarters
Position history for UBS Group AG's holdings in Clementia Pharmaceuticals Inc.
UBS Group AG previously held 0 shares of CMTA (Clementia Pharmaceuticals Inc.), worth $0 as of 2019-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$128,000
Total Shares Change
-4,918
Quarter-by-Quarter History
Other major holders of CMTA: BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., TUDOR INVESTMENT CORP ET AL, DRIEHAUS CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC.